These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28807661)

  • 1. State programs assisting pharmacy professionals with substance use disorders.
    Light KE; Goodner K; Seaton VA; Boyle B; Hopkins R
    J Am Pharm Assoc (2003); 2017; 57(6):704-710. PubMed ID: 28807661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and abuse of controlled substances by pharmacists and pharmacy students.
    McAuliffe WE; Santangelo SL; Gingras J; Rohman M; Sobol A; Magnuson E
    Am J Hosp Pharm; 1987 Feb; 44(2):311-7. PubMed ID: 2882673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Professional impairment: a history and one state's response.
    Pooler D; Sheheen F; Davidson J
    J Addict Dis; 2009; 28(2):113-23. PubMed ID: 19340673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' advancing roles in drug and disease management: a review of states' legislation.
    McKnight AG; Thomason AR
    J Am Pharm Assoc (2003); 2009; 49(4):554-8. PubMed ID: 19589769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of suicide prevention programs and training policies for pharmacists.
    Carpenter DM; Lavigne JE; Roberts CA; Zacher J; Colmenares EW
    J Am Pharm Assoc (2003); 2018; 58(5):522-529. PubMed ID: 30017371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a rehabilitation program for impaired pharmacists.
    Sheffield JW
    Am J Hosp Pharm; 1988 Oct; 45(10):2092-8. PubMed ID: 3228080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current practices and state regulations regarding telepharmacy in rural hospitals.
    Casey MM; Sorensen TD; Elias W; Knudson A; Gregg W
    Am J Health Syst Pharm; 2010 Jul; 67(13):1085-92. PubMed ID: 20554595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Michigan's unique approach to treating impaired health care professionals.
    Fletcher CE
    J Addict Dis; 2001; 20(4):97-111. PubMed ID: 11760930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding clinical and information services to the ambulatory older adult through community outreach programs.
    Evans P; Aungst TD; Massey C; Bartlett D
    Consult Pharm; 2015 Jan; 30(1):31-7. PubMed ID: 25591029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opinions and experiences of Indiana pharmacists and student pharmacists: the need for addiction and substance abuse education in the United States.
    Wenthur CJ; Cross BS; Vernon VP; Shelly JL; Harth BN; Lienhoop AD; Madison NR; Murawski MM
    Res Social Adm Pharm; 2013; 9(1):90-100. PubMed ID: 22695219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with a drug screening program at a school of pharmacy.
    Cates ME; Hogue MD
    J Am Coll Health; 2012; 60(6):476-80. PubMed ID: 22857140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with substance abuse in the workplace.
    Malatestinic WN; Jorgenson JA
    Hosp Pharm; 1991 Feb; 26(2):102-5. PubMed ID: 10170679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description and comparison of pharmacy technician training programs in the United States.
    Anderson DC; Draime JA; Anderson TS
    J Am Pharm Assoc (2003); 2016; 56(3):231-6. PubMed ID: 27083853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery assistance programs help pharmacists with substance abuse problems.
    Young D
    Am J Health Syst Pharm; 2003 Dec; 60(24):2544, 2547-8. PubMed ID: 14735770
    [No Abstract]   [Full Text] [Related]  

  • 15. The Educating Pharmacy Students and Pharmacists to Improve Quality program: tool for pharmacy practice.
    Warholak TL; West D; Holdford DA
    J Am Pharm Assoc (2003); 2010; 50(4):534-8. PubMed ID: 20621874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.
    Rupp MT; Warholak TL
    J Am Pharm Assoc (2003); 2008; 48(3):364-70. PubMed ID: 18595821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy technician-to-pharmacist ratios: a state-driven safety and quality decision.
    Bess DT; Carter J; DeLoach L; White CL
    J Am Pharm Assoc (2003); 2014; 54(6):648-51. PubMed ID: 25343210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and delivery of a pharmacist training program to increase naloxone access in Kentucky.
    Palmer E; Hart S; Freeman PR
    J Am Pharm Assoc (2003); 2017; 57(2S):S118-S122. PubMed ID: 28161300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.